Latanoprost lactonediol
CAS: 145667-75-0
Ref. 3D-FL146893
| 25mg | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado | ||
| 250mg | Descontinuado | ||
| 500mg | Descontinuado |
Informação sobre produto
Nome:
Latanoprost lactonediol
Sinónimos:
- (3Ar,4R,5R,6As)-Hexahydro-5-Hydroxy-4-[(3R)-3-Hydroxy-5-Phenylpentyl]-2H-Cyclopenta[B]Furan-2-One
- (3Ar,4R,5R,6As)-5-Hydroxy-4-((3R)-3-Hydroxy-5-Phenylpentyl)Hexahydrocyclopenta[B]Furan-2-One
- Lp-Diol (Lt-Di)(Latanprost)
- (3Ar,4R,5R,6As)-5-Hydroxy-4-[(3R)-3-Hydroxy-5-Phenylpentyl]Hexahydro-2H-Cyclopenta[B]Furan-2-One
- 2H-Cyclopenta[B]Furan-2-One, Hexahydro-5-Hydroxy-4-[(3R)-3-Hydroxy-5-Phenylpentyl]-, (3Ar,4R,5R,6As)-
Descrição:
Latanoprost lactonediol is a prostaglandin derivative that is used as an intermediate in the synthesis of bimatoprost and travaprost. Latanoprost lactonediol has been shown to be effective for the treatment of glaucoma, ocular hypertension, and other diseases related to increased intraocular pressure. This drug also has been shown to be effective for the treatment of hypotension caused by septic shock. The chemical process for latanoprost lactonediol is similar to that of bimatoprost and travaprost.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
304.38 g/mol
Fórmula:
C18H24O4
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
